The appropriateness of finerenone initiation, dosing, and outcomes in diabetic kidney disease: data from real world practice

Abstract Background Finerenone has been shown to improve renal outcomes in patients with diabetic kidney disease. Appropriate use according to the Kidney Disease: Improving Global Outcomes (KDIGO) guideline criteria are essential to maximize its clinical benefit. However, the initiation and monitori...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Phatadon Sirivongrangson, Sorapop Pakdeewongse, Phraelada Kumnuch, Teerapol Punjachaipornpol, Nattachai Srisawat
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2026-03-01
Цуврал:	BMC Nephrology
Нөхцлүүд:	Finerenone Chronic kidney disease Real-world study Diabetic kidney disease Albuminuria
Онлайн хандалт:	https://doi.org/10.1186/s12882-026-04882-5
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!